Dimensional Fund Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $416K | Buy |
+183,166
| New | +$416K | ﹤0.01% | 3022 |
|
|
2023
Q3 | – | Sell |
-35,865
| Closed | -$61.7K | – | 3475 |
|
|
2023
Q2 | $61.7K | Sell |
35,865
-120,591
| -77% | -$207K | ﹤0.01% | 3387 |
|
|
2023
Q1 | $236K | Sell |
156,456
-16,116
| -9% | -$24.3K | ﹤0.01% | 3168 |
|
|
2022
Q4 | $276 | Sell |
172,572
-8,008
| -4% | -$13 | ﹤0.01% | 3159 |
|
|
2022
Q3 | $262K | Sell |
180,580
-216,661
| -55% | -$314K | ﹤0.01% | 3190 |
|
|
2022
Q2 | $727K | Sell |
397,241
-411,899
| -51% | -$754K | ﹤0.01% | 2984 |
|
|
2022
Q1 | $2.16M | Buy |
809,140
+287,113
| +55% | +$767K | ﹤0.01% | 2808 |
|
|
2021
Q4 | $2.26M | Buy |
522,027
+198,998
| +62% | +$862K | ﹤0.01% | 2814 |
|
|
2021
Q3 | $1.64M | Sell |
323,029
-311,364
| -49% | -$1.58M | ﹤0.01% | 2906 |
|
|
2021
Q2 | $4.02M | Buy |
634,393
+119,342
| +23% | +$755K | ﹤0.01% | 2668 |
|
|
2021
Q1 | $3.98M | Sell |
515,051
-38,853
| -7% | -$300K | ﹤0.01% | 2649 |
|
|
2020
Q4 | $3.63M | Sell |
553,904
-16,700
| -3% | -$109K | ﹤0.01% | 2633 |
|
|
2020
Q3 | $3.8M | Hold |
570,604
| – | – | ﹤0.01% | 2539 |
|
|
2020
Q2 | $4.75M | Sell |
570,604
-23,063
| -4% | -$192K | ﹤0.01% | 2492 |
|
|
2020
Q1 | $4.55M | Buy |
593,667
+24,103
| +4% | +$185K | ﹤0.01% | 2449 |
|
|
2019
Q4 | $4.73M | Buy |
569,564
+162,919
| +40% | +$1.35M | ﹤0.01% | 2627 |
|
|
2019
Q3 | $3M | Buy |
406,645
+57,451
| +16% | +$424K | ﹤0.01% | 2759 |
|
|
2019
Q2 | $3.92M | Buy |
349,194
+208,619
| +148% | +$2.34M | ﹤0.01% | 2720 |
|
|
2019
Q1 | $1.51M | Buy |
140,575
+95,460
| +212% | +$1.03M | ﹤0.01% | 2949 |
|
|
2018
Q4 | $681K | Buy |
+45,115
| New | +$681K | ﹤0.01% | 3098 |
|